Hello, everyone, and nice to see you again. We hope your weekend was relaxing and refreshing. Now, of course, the time has come to resume the routine as those meetings and deadlines beckon. We know the feeling. To cope, we are brewing our usual cup of stimulation - our flavor today is Pumpkin Spice - and we invite you to join us. Meanwhile, here are some interesting tidbits to help you along. Hope your day goes well and do stay in touch...
Supreme Court Rejects Vanderbilt Bid On Lilly Cialis Patent (Indianapolis Star)
Glaxo Stopped Running Levitra Ads In Late 2009 (Dow Jones)
EU Price Cuts And US Reform Weigh On Drugmakers (Reuters)
Sanofi Extends Genzyme Bid To February 15 (Bloomberg News)
China Health Deal To Boost US Pharma Exports (Pharma Times)
Families Drop Case Against Epilepsy Drug (BBC)
Novartis Buys Genoptix Diagnostics Lab For $470M (Bloomberg News)
States Face Shortage Of Lethal Injection Drug (New York Times)
NPS Pharmaceuticals Tries For A Comeback (The Star-Ledger)
AstraZeneca R&D Chief Talks About Drug Discovery (Dow Jones)
Baxter Employee Dies From Ethanol Fumes (Los Angeles Times)
FDA Approves Antidepressant Without Sexual Side Effects (Bloomberg News)
Australian Docs Criticize Leukemia Drug (Sydney Morning Herald)
Amgen Increases Prices To Offset Aranesp Slide (Bloomberg News)
InVentiv Buys i3 And Campbell Alliance (Outsourcing Pharma)
India Exports Will Require Barcodes By July (InPharma-Techhnologist)